Abbott (NYSE: ABT) today announced CE Mark in Europe for the XIENCE Xpedition 48 Everolimus Eluting Coronary Stent System, the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE